An Overview on Novel Coronavirus (COVID-19)

Authors: Suresh G , Shreyas P and Rajeshwari O

DOI: 10.23880/nnoa-16000183

Volume 5, Issue 2

Abstract

In December 2019, a novel coronavirus (COVID-19) was reported in Wuhan, a city of 11 million people in central China. The initial cases were connected to exposures in a seafood market in Wuhan [1]. As of March 31, 2020, the WHO reported 697244 confirmed cases and 33257 confirmed deaths in 204 countries of the whole world. The infected people were experienced respiratory illness and coughs. Therefore, pathogen was soon identified as a COVID-19 which is closely related to sever acute respiratory syndrome CoV(SARS-CoV). Currently, there is no completely specific treatment against the COVID-19. Therefore, identifying effective antiviral medicines to combat the disease is an imperatively needed. An efficient approach to effective drug discovery is to test whether the existing antiviral drugs are effective in treating related COVID-19 viral infections. Also, clinical researches are rapidly growing on to find out the solution of COVID-19.

Keywords: Coronavirus; COVID-19; Pathogen

View PDF